Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025MedicinaOpen Access

Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAli Alper SolmazIBIlhan BirsenogulAKAygül Polat Kelle

Discussion

Loading...

Member takes

Overview

Retrospective cohort study shows metabolic tumor volume and indices predict survival in DLBCL patients, suggesting improved risk assessment.

Key Points

  • Significantly shorter overall survival linked to SUVmaxliver ≤ 22 and HI2 > 62.3, indicating the importance of these measures.
  • Mean overall survival and relapse-free survival were 71.6 months and 38.7 months respectively, providing concrete survival data.
  • Analysis included 70 patients with diffuse large b-cell lymphoma, using methods like Kaplan-Meier to assess survival outcomes.
  • Results highlight the need for personalized therapy based on metabolic and inflammatory markers for better patient management.

Cite This Study

Solmaz et al. (2025) studied this question.

synapsesocial.com/papers/68c2404eb210217d6479a50ehttps://doi.org/10.3390/medicina61081370
View Full Paper
Ask AI
Bookmark
Share